Open AccessAdenosine deaminase 2 deficiency with a novel variant of CECR1 gene mutation: Responding to tumor necrosis factor antagonist therapy
Author(s) -
Zakiya Saleh Al Mosawi,
Hiba Abduljawad,
Maryam Busehail,
Barrak Mahmood Al Moosawi
Publication year - 2019
Publication title -
indian journal of rheumatology/indian journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 11
eISSN - 0973-3701
pISSN - 0973-3698
DOI - 10.4103/injr.injr_36_19
Subject(s) - adenosine deaminase , tumor necrosis factor alpha , gene , mutation , antagonist , adenosine deaminase deficiency , genetic enhancement , tumor necrosis factor α , adenosine , genetics , cancer research , medicine , biology , immunology , receptor